Health Canada inspection
Novartis Pharmaceuticals Corporation: Health Canada inspection of Mar 29, 2018
Health Canada · GMP · rating C
Key facts
| Establishment | Novartis Pharmaceuticals Corporation |
|---|---|
| City | East Hanover |
| Province | NJ |
| Country | United States |
| Program | GMP |
| Start date | Mar 26, 2018 |
| End date | Mar 29, 2018 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.